UK hopes planned 1B cancer research hub will attract biotechs

on

Title

UK’s £1 Billion Cancer Research Hub Aims to Create Leading Life Sciences Cluster and Attract Biotech Innovation

Keywords

  • UK cancer research hub
  • London Cancer Hub
  • biotech attraction
  • life sciences cluster
  • Aviva Capital Partners
  • Socius
  • Sutton cancer research
  • The Institute of Cancer Research
  • The Royal Marsden
  • research and laboratory space
  • R&D jobs
  • economic impact

Key Facts

  • The UK is planning a £1 billion cancer research and treatment hub in Sutton, London, as part of an effort to attract leading biotech companies and position the country as a global center for oncology innovation25.

  • The facility, developed by Aviva Capital Partners and Socius, will span 12 acres and offer around 1 million square feet of state-of-the-art research and laboratory space, designed to foster collaboration among biotech firms, academic researchers, and clinicians125.

  • The hub will be located at the London Cancer Hub, adjacent to The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust—two leading institutions in cancer research and treatment123.

  • The project is expected to create 3,000 new high-skilled jobs in life sciences R&D and small-scale manufacturing, increasing the total workforce at the London Cancer Hub to 13,00012.

  • The hub is projected to add approximately £1.2 billion per year to the UK economy (Gross Value Added) when fully operational12.

  • The proposed ecosystem aims to attract both large pharmaceutical companies and innovative biotech start-ups with top-tier wet labs, GMP (Good Manufacturing Practice) facilities, flexible workspaces, and modern office amenities5.

  • The design emphasizes an open, collaborative campus to promote idea exchange and interdisciplinary partnerships, with the first phase targeted for completion by 2028 if approved45.

  • The development is being presented as one of the most ambitious life sciences clusters in Europe dedicated solely to cancer research and treatment5.

  • Planning approval from the London Borough of Sutton is pending; if granted, construction is expected to begin in 202545.

Sources:

1. https://www.biopharminternational.com/view/new-cancer-research-and-treatment-center-in-development-in-london

2. https://www.aviva.com/newsroom/news-releases/2025/05/aviva-capital-partners-and-socius-submit-plans-for-one-billion-pounds-development/

3. https://www.icr.ac.uk/about-us/icr-news/detail/icr-welcomes-plans-for--1-billion-development-to-create-world-leading-cancer-research-district-in-sutton

4. https://www.cretech.com/news/https-www-standard-co-uk-business-sutton-cancer-research-treatment-oncology-royal-marsden-b1225257-html/

5. https://bdcmagazine.com/2025/05/sutton-set-to-host-1bn-cancer-research-powerhouse-in-major-life-sciences-expansion/